Petten HFR Will Produce Medical Isotopes Only With LEU The High Flux Reactor in Petten, operated by NRG, from now on produces only medical isotopes with low-enriched uranium (LEU). Until recently, the productions for NRG’s Belgian partner IRE were still based on high-enriched uranium, because IRE could not fully process low-enriched uranium. But now IRE…
NRG Safety Committee Approved Restart Solution For HFR In Petten The High-Flux Reactor (HFR) in Petten, Netherlands, did not start up on 20 January 2022, due to a leak in a water system. NRG (ENS Corporate Member) reported no risk to nuclear safety, man, or the environment. Since the discovery of the technical failure in…
IAEA Mission On Ageing Management Of The High Flux Reactor In Petten From 21 to 28 June, a team of seven international experts visited NRG’s High Flux Reactor (HFR) in Petten on behalf of the International Atomic Energy Agency (IAEA) to examine the ageing management of installations. NRG celebrated the reactor’s sixtieth anniversary last year,…
NRG Starts Irradiating Nuclear Reactor Containment Tubes For EDF In December 2020 EDF (Électricité de France) and NRG (both ENS Corporate Members) have started a cooperation on the irradiation of containment tubes. The purpose of the irradiation is to gain knowledge on the behavior of containment tubes under operating conditions that are to be considered…
High Flux Reactor In Petten Started Up In Advance The High Flux Reactor (HFR) in Petten, operated by NRG (ENS Corporate Member) started up a day early after maintenance to increase the availability of medical isotopes. The HFR has about 260 production days per year and has regular short maintenance shutdowns, and twice a year…
NCBJ And JAEA To Boost Research And Development In HTGRs On November 22, in Tokyo, the President of the Japanese Atomic Energy Agency (JAEA), Mr. Koguchi Masanori and the Director of the Polish National Centre for Nuclear Research (NCBJ), Prof. Krzysztof Kurek signed an Implementing Arrangement regarding the institution’s cooperation in research and development in…
NRG|PALLAS Started The First Irradiation Cycle Of 2024 For Lutetium Last week, NRG|PALLAS (ENS Corporate Member) announced the launch of the first cycle of irradiation of the year focusing on lutetium for medical applications. The Dutch company, operating the High Flux Reactor in Petten (The Netherlands), said the cycle started on 19 January, with the…
Steps Forward for the PALLAS Reactor NRG PALLAS (ENS Corporate Member) announced the completion of the construction pit and the foundation, marking the end of this phase of the PALLAS project. This has laid the foundation for the next phase of construction. The arrival of the PALLAS-reactor is crucial for the production of medical isotopes.…